Why is Aarti Drugs falling/rising?

As of 03-Sep, Aarti Drugs Ltd's stock price is currently at 487.90, reflecting an increase of 17.6 or 3.74%. The stock has shown a positive performance today, outperforming its sector by 2.5% and reaching an intraday high of Rs 496.9, which is a rise of 5.66%. In the past week, the stock has gained 3.54%, while it has seen a slight decline of 0.31% over the past month. Despite a significant drop of 16.27% over the past year, the company has reported a 20.4% increase in profits, contributing to a PEG ratio of 1.2, indicating attractive valuation. The stock is trading at a discount compared to its peers, supported by a high management efficiency reflected in a ROCE of 17.84% and a low debt-to-equity ratio of 0.45.
In the broader market context, the Sensex has experienced a minor decline of 0.27% over the past week, while Aarti Drugs has managed to rise, indicating relative strength against the benchmark. The stock's year-to-date performance shows a gain of 5.92%, outperforming the Sensex's 3.11% increase. The rising investor participation, evidenced by a 76.21% increase in delivery volume, suggests growing interest in the stock, further supporting its upward movement. Overall, the combination of positive financial metrics and favorable trading activity has contributed to the stock's recent rise.